Quality Site Head
CRISPR Therapeutics
Quality Site Head
CRISPR Therapeutics
Develops gene-editing therapies using CRISPR
Job Description:
Company Overview
Founded over a decade ago, CRISPR Therapeutics is a leading biopharmaceutical company focused on developing transformative gene-based medicines for serious human diseases. The Company has evolved from a pioneering research-stage organization into an industry leader, marking a historic milestone with the approval of CASGEVY® (exagamglogene autotemcel [exa-cel]), the world’s first CRISPR-based therapy, approved for eligible patients with sickle cell disease and transfusion-dependent beta thalassemia. CRISPR Therapeutics is advancing a broad and diversified pipeline across hemoglobinopathies, cardiovascular, autoimmune, oncology, regenerative medicine and rare diseases. The Company continues to expand its leadership in gene editing through the development of SyNTase™ editing, a novel and proprietary gene-editing platform designed to enable precise, efficient, and scalable gene correction. To accelerate and expand its impact, CRISPR Therapeutics has established strategic collaborations with leading biopharmaceutical partners, including Vertex Pharmaceuticals. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Boston, Massachusetts and San Francisco, California.
Position Summary
Reporting to the Vice President, Head of Quality, the Quality Site Head will play a key leadership role both at CRISPR’s internal manufacturing site and within the Quality Assurance function as a whole. The ideal candidate will lead by example to promote excellence in every aspect of internal manufacturing operations as part of CRISPR’s mission to develop impactful therapies at the forefront of gene-editing technology.
Responsibilities
Minimum Qualifications
Preferred Qualifications
Competencies
Due to the nature of their work, our manufacturing and lab-based positions are located fully on-site.
Quality Site Head: Base pay range of $230,000 to $250,000+ bonus, equity and benefits
The range provided is CRISPR Therapeutics’ reasonable estimate of the base compensation for this role. The actual amount will be based on job-related and non-discriminatory factors such as experience, training, skills, and abilities.
CRISPR Therapeutics, Inc. is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person's race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law.
To view our Privacy Statement, please click the following link: http://www.crisprtx.com/about-us/privacy-policy
Develops gene-editing therapies using CRISPR
CRISPR Therapeutics develops gene-editing medicines using CRISPR/Cas9 to treat serious diseases, targeting conditions like sickle cell disease and cancer. Its therapies involve editing patient cells either outside the body (ex vivo) or inside the body (in vivo) to correct disease-causing genes, followed by clinical testing and potential commercialization. The company differentiates itself through a strategy of pursuing partnerships and licensing deals to fund its pipeline and accelerate development, alongside its own research and clinical programs. Its goal is to provide durable, disease-modifying treatments that address unmet medical needs for patients worldwide through a global biopharmaceutical approach.
Explore more opportunities at CRISPR Therapeutics